Abstract
Calcium pyrophosphate dihydrate (CPPD) crystal deposition disease is a clinically heterogeneous disorder that is characterized by the presence of intraarticu-lar CPPD crystals. CPPD crystals deposit primarily in cartilage but can traffic within the joint space. CPPD crystals form in the normally unmineralized peri-cellular matrix of articular hyaline and fibrocartilage. The most common sites of involvement are the knee meniscus, the triangular fibrocartilage of the wrist, and the glenohumeral joint. Asymptomatic disease is common in these sites as well as in others (e.g., the symphy-sis pubis). Pathologic cartilage calcification is promoted by changes in inorganic pyrophosphate (PPi) metabolism, extracellular matrix, and chondrocyte differentiation. CPPD deposition disease has a close and complex relationship with osteoarthritis. CPPD most commonly afflicts the elderly but can occur in younger patients who have a familial variant of the condition or who are afflicted with any of several metabolic diseases that predispose to CPPD deposition. No specific evidence-based therapies for CPPD exist. However, the inflammation promoted by CPPD crystal deposition can be managed successfully in most patients through strategies typically employed for the treatment and prophylaxis of gout.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alloway J, Moriarty M, Hoogland Y, et al Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis J Rheumatol. 1993;20:111–3
Chollet-Janin A, Finckh A, Dudler J, et al Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis. Arthritis Rheum. 2007;56:688–92
Dieppe P, Crocker P, Corke C, et al Synovial fluid crystals. Q J Med. 1979;48:533–55
Doan TH, Chevalier X, Leparc JM, et al Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al Arthritis Rheum. 2008;58:2210–1
Ellman MH, Levin B. Chondrocalcinosis in elderly persons. Arthritis Rheum. 1975;18:43–7
Fisseler-Eckhoff A, Muller KM. Arthroscopy and chondrocalcinosis. Arthroscopy 1992;8:98–104
Galvez J, Saiz E, Linares L, et al Delayed examination of synovial fluid by ordinary and polarized light microscopy to detect and identify crystals. Ann Rheum Dis. 2002;61:444–7
Gerster J, Varisco P, Kern J, et al CPPD crystal deposition disease in patients with rheumatoid arthritis. Clin Rheumatol. 2006;25:468–9
Gordon C, Swan A, Dieppe P. Detection of crystals in synovial fluid by light microscopy: sensitivity and reliability. Ann Rheum Dis. 1989;48:737–42
Goto S, Umehara J, Aizawa T, et al Crowned dens syndrome. J Bone Joint Surg Am. 2007;89:2732–6
Hasselbacher P. Variation in synovial fluid analysis by hospital laboratories. Arthritis Rheum. 1987;30:637–42
Hearn P, Russell R, Elliott J, et al Formation products of calcium pyro-phosphate crystals in vitro and the effect of iron salts. Clin Sci. 1978;54:29P
Job-Deslandre C, Menkes CJ, Guinot M, et al Does hypothyroidism increase the prevalence of chondrocalcinosis? Br J Rheumatol. 1993;32:177–9
Komatireddy GR, Ellman MH, Brown NL. Lack of association between hypothyroidism and chondrocalcinosis. J Rheumatol. 1989;16:807–8
Martinez-Sanchis A, Pascual E. Intracellular and extracellular CPPD crystals are a regular feature in synovial fluid from uninflamed joints of patients with CPPD related arthropathy. Ann Rheum Dis. 2005; 64:1769–72
Masuda I, Ishikawa K. Clinical features of pseudogout attack: a survey of 50 cases. Clin Orth Rel Res. 1987;229:173–81
McCarty DJ. Diagnostic mimicry in arthritis: patterns of joint involvement associated with calcium pyrophosphate dihydrate crystal deposits. Ann Rheum Dis. 1975;25:804–9
Mitrovic D, Stankovic A, Iriarte-Borda O, et al The prevalence of chon-drocalcinosis in the human knee joint. An autopsy survey. J Rheumatol. 1988;15:633–41
Neogi T, Nevitt M, Niu J, et al Lack of association between chondrocal-cinosis and increased risk of cartilage loss in knees with osteoarthri-tis: results of two prospective longitudinal magnetic resonance imaging studies. Arthritis Rheum. 2006;54:1822–8
O'Duffy J. Clinical studies of acute pseudogout attacks. Comments on prevalence, predisposition and treatment. Arthritis Rheum. 1976;19 (Suppl):349–52
Roane D, Harris M, Carpenter M, et al Prospective use of intramuscular triamcinolone in pseudogout. J Rheumatol. 1997;24:1168–70
Rosenthal AK. Calcium crystal deposition and osteoarthritis. Rheum Dis Clin North Am. 2006;32:401–12
Schumacher H, Sieck M, Rothfuss S, et al Reproducibility of synovial fluid analyses. Arthritis Rheum. 1986;29:770–4
Terkeltaub R. Firestein GS, Budd RC, Harris ED, Jr., Mclnnes IB, Ruddy S, Sergent JS. Diseases associated with articular deposition of calcium pyrophosphate dihydrate and basic calcium phosphate crystals. In: Firestein G et al, editor. Kelley's textbook of rheumatology, 8th ed, WB Saunders, Philadelphia, 2008
Viriyavejkul P, Wilairatana V, Tanavalee A, et al Comparison of characteristics of patients with and without calcium pyrophosphate dihy-drate crystal deposition disease who underwent total knee replacement surgery for osteoarthritis. Osteoarthr Cartil 2006;13: 232–5
Visinoni RA, Ferraz MB, Furlanetto RP, et al Hypothyroidism and chondrocalcinosis: new evidence for lack of association between the 2 pathologies. J Rheumatol. 1993;20:1991–2
Wilkins E, Dieppe P, Maddison P, et al Osteoarthritis and articular chondrocalcinosis in the elderly. Ann Rheum Dis. 1983;42: 280–4
Yuan S, Bien C, Wener M, et al Repeat examination of synovial fluid for crystals: Is it useful? Clin Chem. 2003;49:1562–3
Zaka R, Williams CJ. Role of the progressive ankylosis gene in cartilage mineralization. Curr Opin Rheumatol. 2006;18:181–6
Zhang Y, Johnson K, Russell RG, et al Association of sporadic chondro-calcinosis with a -4-basepair G-to-A transition in the 5′-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate. Arthritis Rheum. 2005;52:1110–7
Zhang Y, Terkeltaub R, Nevitt M, et al Lower prevalence of chondrocal-cinosis in Chinese subjects in Beijing than in white subjects in the United States: the Beijing Osteoarthritis Study. Arthritis Rheum. 2006;54:3508–12
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Rosenthal, A.K., Terkeltaub, R.A. (2009). Calcium Pyrophosphate Dihydrate (CPPD) Crystal Deposition Disease. In: Stone, J.H. (eds) A Clinician's Pearls and Myths in Rheumatology. Springer, London. https://doi.org/10.1007/978-1-84800-934-9_37
Download citation
DOI: https://doi.org/10.1007/978-1-84800-934-9_37
Publisher Name: Springer, London
Print ISBN: 978-1-84800-933-2
Online ISBN: 978-1-84800-934-9
eBook Packages: MedicineMedicine (R0)